AstraZeneca Pharma gains on signing LoI with Strand Life Sciences
Astrazeneca Pharma India is currently trading at Rs. 6260.00, up by 93.80 points or 1.52% from its previous closing of Rs. 6166.20 on the BSE.
The scrip opened at Rs. 6155.05 and has touched a high and low of Rs. 6389.00 and Rs. 6155.05 respectively. So far 83 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 9449.00 on 18-Nov-2025 and a 52 week low of Rs. 5660.00 on 09-Oct-2026.
Last one week high and low of the scrip stood at Rs. 6,548.75 and Rs. 5910.00 respectively. The current market cap of the company is Rs. 15408.50 crore.
The promoters holding in the company stood at 75.00%, while Institutions and Non-Institutions held 9.72% and 15.28% respectively.
AstraZeneca Pharma India has signed a Letter of Intent (LoI) with Strand Life Sciences (Strand), a genomics research and diagnostics company and a subsidiary of Reliance Industries. The LoI aims to explore opportunities to collaborate in healthcare in India.
